Glaukos officer proposes $1.4M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GLAUKOS Corp officer Alex R. Thurman reported a proposed sale of 10,000 common shares, with an aggregate market value of $1,400,000 and an approximate sale date of April 30, 2026. The shares are listed as acquired from the issuer through options granted October 6, 2016.
The notice lists a Rule 10b5-1 plan adoption date of December 15, 2025. It also reports sales during the preceding three months: 625 shares for gross proceeds of $61,968.75 on March 17, 2026; 1,521 shares for $160,070.04 on March 24, 2026; and 2,511 shares for $267,321.06 on March 25, 2026.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Aggregate Market Value financial
Gross Proceeds financial
Options Granted financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.